Evidence map›Paper›PMID 34305621›Full record

ArticleFrontiers in pharmacology2021

Caveolin-1 Alleviates Acetaminophen-Induced Fat Accumulation in Non-Alcoholic Fatty Liver Disease by Enhancing Hepatic Antioxidant Ability

Jiarong Wang, Wei Jiang, Jiao Xin, Weiju Xue, Congjian Shi, Jiagen Wen, Yan Huang, Chengmu Hu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jiarong WangInflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China.
Wei JiangInflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China.
Jiao XinInflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China.
Weiju XueInflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China.
Congjian ShiInflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China.
Jiagen WenInflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China.
Yan HuangInflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China.
Chengmu HuInflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China.
Ministry of Education of the People's Republic of China · CNAnhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD) is an independent risk factor for acute liver injury caused by overuse of acetaminophen (APAP). Caveolin-1 (CAV1), a regulator of hepatic energy metabolism and oxidative stress, was found to have a protective effect against NAFLD in our previous study. However, it remains unclear whether CAV1 has a protective effect against APAP-induced hepatotoxicity in NAFLD. The aim of this study was to determine whether CAV1 inhibits oxidative stress through the AMPK/Nrf2/HO-1 pathway to protect the liver from fat accumulation exacerbated by APAP in NAFLD. In this study, seven-week-old C57BL/6 male mice (18-20 g) were raised under similar conditions for

Indexed as

acetaminophenadenosine monophosphate-activated protein kinasecaveolin-1non-alcoholic fatty liver diseaseoxidative stress

Identifiers

PMID34305621
PMCPMC8293675
OpenAlexW3177911656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.